Search

everythinglearnresearchcommunity

for

Search:↓

Croton membranaceus root extract can change how drugs are processed in the body.

Mint water extract boosts protective enzymes in skin cells.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Docetaxel is safe and works well for older people with cancer, with manageable side effects.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

Epristeride's metabolism in zebrafish helps improve doping detection methods.

Docetaxel is effective against various cancers but mainly causes neutropenia.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

The WNT signaling pathway is important in many diseases and targeting it could offer new treatments.

PLD is an effective and safer alternative for treating breast cancer.

DPK-060 in poloxamer gel effectively treats skin infections, but nanocarriers don't enhance its efficacy.

New butyric acid prodrugs show promise for cancer treatment, anemia management, and protecting hair from chemotherapy damage.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

A blood pressure drug, diltiazem, may also help treat influenza.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Compounds from certain trees used by First Nations people show potential for treating skin conditions and promoting hair growth, but more research is needed to confirm their safety and effectiveness.